ArticleScientific reports2025
Extraction of mango seed kernels via super fluid extraction and their anti-H. pylori, anti-ovarian and anti prostate cancer properties.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the discovery of many plant-based drugs, research is still ingoing, in addition to using safer and more effective methods in the extraction process. Presently, Super Fluid Extraction (SFE) was applied to extract the mango seed kernels (MSK) at two operating temperatures 30 and 50 °C with studying their biological activities. MSK extract via SFE at operating temperatures 30 °C showed high yield 0.268 g compared to that at 50 °C. High-performance liquid chromatography (HPLC) analysis demonstrated high content of compounds such as gallic acid (68503.01 µg/mL), chlorogenic acid (6541.68 µg/mL), ferulic acid (2555.12 µg/mL) and ellagic acid (2479.42 µg/mL) MSK while at 50 °C the concentrations were low. Helicobacter pylori was highly inhibited by MSK extract via SFE at operating temperature 30 °C with inhibition zone 29.17 ± 0.29 mm, MIC 15.62 µg/mL and MBC 31.25 µg/mL, while at operating temperature 50 °C the inhibition zone was 24.67 ± 0.58 mm, MIC was 62.5 µg/mL and MBC was 125 µg/mL. Moreover, low hemolysis was recorded by H. pylori treated by MSK extract via SFE at operating temperature 30 °C compared to that at 50 °C. Excellent antioxidant with IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.